Z
ZetrOZ
Sustained Acoustic Medicine | ZetrOZ Systems, LLC | ZetrOZ Systems, LLC
About ZetrOZ
ZetrOZ Systems is a pioneering company in the field of mechanobiology, specializing in the development of advanced medical treatments using sustained acoustic medicine (SAM) technology. The company serves a diverse range of clients including orthopedic surgeons, sports medicine physicians, physical therapists, and other healthcare practitioners. Operating in the medical technology market, ZetrOZ Systems focuses on creating wearable ultrasound devices that provide long-duration pain relief and promote accelerated healing. Their flagship product, the SAM X1, is the only FDA-cleared multi-hour ultrasound device, making it a unique offering in the market. The business model revolves around selling these innovative medical devices directly to healthcare providers and through partnerships with institutions like the National Institute of Aging and the National Institutes of Health. Revenue is generated through product sales, clinical education programs, and ongoing research collaborations.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Trumbull, United States
- Employees
- 39
- Open positions
- 5
- Dealroom signal
- 86.1/100
- Industry
- Health, Sports
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- SaaS
- Client focus
- b2c
- Investment activity
- 1 company, latest Jun 2013
- Capital deployed
- $2M
- Preferred round
- SERIES A
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Oct 2024 | $20K | — | Undisclosed | ↗ |
| SPINOUT✓Other financing | Jan 2016 | $0 | — | Cornell University | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for ZetrOZ is 4.6K monthly website visits, up 109.1% over the last three months. ZetrOZ's team grew 18.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Boston Harbor Angels
Horizon Technology
Series A4 investors entered at this stage
Connecticut Innovations
Standard Oil Ventures- FAFort Point Angels
Maine Angels
Series B and later1 investor entered at this stage
Horizon Technology Finance Corporation
Other known investors4 additional known investors
Cornell University- BLBen Littauer
- MAMass Medical Angels
Oleg Uritsky
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about ZetrOZ on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ZetrOZ’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.